Chat with us, powered by LiveChat Describe dermatitis, diagnostic criteria, and treatment modalities Describe the drug therapy for Conjunctivitis and Otitis Media? Discuss Herpes Virus infections, patient presentation, - Essayabode

Describe dermatitis, diagnostic criteria, and treatment modalities Describe the drug therapy for Conjunctivitis and Otitis Media? Discuss Herpes Virus infections, patient presentation,

  1. Describe dermatitis, diagnostic criteria, and treatment modalities
  2. Describe the drug therapy for Conjunctivitis and Otitis Media 
  3. Discuss Herpes Virus infections, patient presentation, and treatment
  4. Describe the most common primary bacterial skin infections and the treatment of choice. 

Submission Instructions:

  • Your initial post should be at least 500 words, formatted and cited in the current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.
    • Each question must be answered individually as in bullet points. 
    • Example: Question 1, followed by the answer to question 1; Question 2, followed by the answer to question 2; and so forth. 

NUR 600

Module 2

Contact Dermatitis

Contact Dermatitis

Definition: alteration in skin reactivity caused by exposure to an external agent

Causes: combination of genetic and environmental factors

Irritant contact dermatitis (ICD): alteration in skin reactivity caused by exposure to any agent that has a toxic effect on the skin

Allergic contact dermatitis (ACD): alteration in skin reactivity caused by exposure to an antigen that causes an immunologic response

Irritant Contact Dermatitis (ICD)

Not an allergic response; result of damage to the water–protein–lipid matrix of the outer layer of the skin

Appears as erythematous, scaly eruption resulting from friction, exposure to a chemical, or thermal injury

Severity depends on condition of the skin, concentration and toxicity of irritant, and length of exposure

Allergic Contact Dermatitis (ACD)

An immunologically mediated response to an allergen (antigen) occurs.

Initial sensitization phase: the host is immunized to the allergen.

Secondary immune response: T cells are key mediators of the reaction and release cytokines, chemokines, and cytotoxins.

Stimulation of local blood vessels, recruitment of immune cells, and subsequent amplification of the sensitization response occurs.

Allergic Contact Dermatitis (cont.)

Within 5 to 7 days after sensitization, there is visual evidence of the response. On subsequent exposures, however, dermatitis may develop within 6 to 18 hours.

Hypersensitivity can occur after one exposure or after years of repeated exposures. Contact dermatitis may spread extensively beyond the area of contact.

Atopic dermatitis (eczema) is a form of allergic dermatitis characterized as a pruritic, chronic inflammatory condition.

Conditions Occurring in Atopic Dermatitis (Eczema)

High concentrations of serum immunoglobulin (Ig) E

Decreased numbers of immunoregulatory T cells

Defective antibody-dependent cellular cytotoxicity

Decreased cell-mediated immunity

Pathogenesis of Atopic Dermatitis

Genetic factors

Adaptive and innate immune response genes

Skin barrier defects

Deficiency in filaggrin (FLG)

May cause increased transepidermal water loss, infection, and inflammation associated with the exposure of cutaneous immune cells to allergens

Immune dysregulation

Lesions Occurring in Atopic Dermatitis

Papules

Erythema

Excoriations

Lichenification

Treatment for Dermatitis

Prevention is the most effective treatment; patient must be aware of triggers and avoid them.

Mild symptoms are treated with cool compresses; baths with colloidal oatmeal; compresses of Burow solution.

If these fail or dermatitis is more extensive, drug therapy is initiated.

Consideration for Initiating Drug Therapy for Dermatitis

Delivery of the drug to the skin

Protection/barrier function

Cosmetic acceptability

Choosing Drug Therapy for Dermatitis

Ointment and gels offer the best delivery and protection barrier; creams are less greasy but less effective.

Solutions are alcohol-based liquids and are useful for treating the scalp because they do not coat the hair.

Lipid-rich moisturizers both prevent and treat ICD.

Barrier creams containing dimethicone or perfluoropolyethers, cotton liners, and softened fabrics help to prevent ICD.

Choosing Drug Therapy for Dermatitis

Goals of Drug Therapy for Dermatitis

Restoration of a normal epidermal barrier

Treatment of inflammation of the skin

Control of itching

Mainstays of Therapy for Dermatitis

Topical corticosteroids

Topical immunosuppressives

Systemic corticosteroids

Antihistamines

Topical Corticosteroids

Safer than systemic steroidal therapy

Effective for smaller outbreaks

Reduce inflammation and buildup of scale

Least potent topical corticosteroid should be used for the shortest possible time

Should be avoided if there are additional bacterial, viral, or fungal skin infections

Not recommended for prophylaxis

Topical Corticosteroid Therapy

Dosage: initiate treatment with an intermediate- or high-potency topical corticosteroid.

Short-term therapy with more potent topical corticosteroids is preferred to longer-term therapy.

Low-potency corticosteroids should be used in the facial and intertriginous.

Maximum recommended length of treatment with topical corticosteroids is 2 weeks for adults and 1 week for children.

Actions of Systemic Corticosteroids

Inhibit cytokine and mediator release

Attenuate mucus secretion

Upregulate beta-adrenergic receptors

Inhibit IgE synthesis

Decrease microvascular permeability

Suppress the influx of inflammatory cells and the inflammatory process

Dosing Systemic Corticosteroids

Tapering dose schedule is recommended:

Starting dose of 1 mg/kg is decreased by 5 mg every 2 days for 2 to 3 weeks.

The entire dose of steroids can be taken at the same time in the morning to minimize sleep disturbances.

Taking the corticosteroids for less than 2 weeks may cause rebound dermatitis, especially with poison ivy.

If dermatitis flares up during the tapering, the dosage can be increased and tapered again.

Topical Immunosuppressives

Act on T cells by suppressing cytokine transcription.

Used in patients with moderate to severe atopic dermatitis who cannot tolerate topical steroids or are not responsive to other treatments, or where there is a concern for topical steroid–induced atrophy.

Tacrolimus and pimecrolimus are the preparations currently available and are applied twice a day until the lesions clear and then for an additional 7 days.

Antihistamines

Used to relieve pruritus associated with contact dermatitis.

Best time to use them is before bed since side effect is drowsiness.

Selecting the Most Appropriate Agent

First-line therapy: a topical corticosteroid preparation with low to intermediate potency applied twice a day

Second-line therapy: a more potent topical corticosteroid or topical immunosuppressants

Third-line therapy: systemic corticosteroids for treating widespread dermatitis; given on a tapered-dose schedule (1 mg/kg, with the dose decreased every 2 days for at least 2 weeks and up to 3 weeks)

Special Populations

Pediatric

Topical corticosteroids should be used for only 7 days in children younger than age 6 and at the lowest potency.

Geriatric

Topical corticosteroids can cause atrophy of the skin in elderly people.

Patient Education

Teaching to avoid causative substance

1

Using mild soaps without perform

2

Demonstrating how to apply topical preparations and occlusive dressing

3

Hydrating the skin before applying medication

4

Hydrating with bland emollients

5

Taking daily soaking baths for 10 to 20 minutes and using moisturizer afterward

6

Complementary and Alternative Medicine

Vitamin A 50,000 international units daily

Vitamin E 400 international units daily

Zinc 50 mg daily, to be decreased as the condition clears

EPA 540 mg and DHA 360 mg daily or flaxseed oil 10 g daily

Evening primrose oil 3,000 mg daily

Fungal Infections of the Skin

Tinea

Tinea versicolor

Candidiasis

Types of Tinea Infections

Tinea capitis: head

Tinea corporis: body

Tinea pedis: foot

Tinea manus: hand

Tinea unguium (onychomycosis): nails

Tinea cruris: groin

Factors Predisposing People to Fungal Infections

Warm, moist, occluded environments

Family history

Compromised immune system

Five Species of Fungus Causing Most Infections

Trichophyton rubrum

Trichophyton tonsurans

Trichophyton mentagrophytes

Microsporum canis

Epidermophyton floccosum

Diagnostic Criteria for Fungal Infections

Symptoms

Pruritus, burning, and stinging of the scalp or skin, possible erythema and vesicles with inflammatory dermal reactions.

Diagnostic tests

Microscopic evaluation of the stratum corneum with 10% potassium hydroxide (KOH) preparation

Fungal culture

Wood lamp (identifies only Microsporum)

Tinea Capitis Presentation

Inflamed, scaly, alopecic patches, especially in infants

Diffuse scaling with multiple round areas with alopecia secondary to broken hair shafts, leaving residual black stumps

“Gray patch” type with round, scaly plaques of alopecia in which the hair shaft is broken off close to the surface

Tender, pustular nodules

Tinea Corporis

Called “ringworm” when it affects the face, limbs, or trunk but not the groin, hands, or feet

Presentation: ring-shaped lesion with well-demarcated margins, central clearing, and a scaly, erythematous border

Causes: contact with infected animals, human-to-human transmission, and from infected mats in wrestling

Organisms responsible: M. canis, T. rubrum, and T. mentagrophytes

Tinea Cruris

Often referred to a “jock itch.”

A fungal infection of the groin and inguinal folds, tinea cruris spares the scrotum.

Causes are T. rubrum or E. floccosum.

Symptoms: lesions that are large, erythematous, and macular, with a central clearing; a hallmark is pruritus or a burning sensation.

Often fungal infection of the feet is present.

Three Types of Tinea Pedis

Interdigital: scaling, maceration, and fissures between the toes

Plantar: diffuse scaling of the soles, usually on the entire plantar surface

Acute vesicular: vesicles and bullae on the sole of the foot, the great toe, and the instep

Characteristics of Tinea Manus

Dermatophyte infection of the hand

Always associated with tinea pedis and usually unilateral

Lesions marked by mild, diffuse scaling of palmar skin

Vesicles may be grouped on the palms or fingernails involved

Tinea Unguium

Fungal infection of the nail; typically the toenails.

Nails become thick and scaly with subungual debris.

Onycholysis (nail separation from bed) may occur.

Under the nail, a hyperkeratotic substance accumulates that lifts the nail up.

Organisms causing onychomycosis: dermatophytes, E. floccosum, T. rubrum, T. mentagrophytes, Candida albicans, Aspergillus, Fusarium, and Scopulariopsis.

Initiating Drug Therapy for Fungal Infections

Prevention: applying powder containing miconazole (Monistat) or tolnaftate (Tinactin) to areas prone to fungal infections after bathing and blow drying on low temperature

Goals of drug therapy: directed against the offending fungus and site of infection; may be topical or systemic depending on location of lesions

Topical Azole Antifungals

Action: work by pairing the synthesis of ergosterol, the main sterol of fungal cell membranes, allowing for increased permeability and leakage of cellular components, resulting in cell death.

Uses: effective against tinea corporis, tinea cruris, and tinea pedis as well as cutaneous candidiasis.

Dosage: applied once or twice a day for 2 to 4 weeks. Therapy should continue for 1 week after the lesions clear.

Topical Allylamine Antifungals

Action: effective against dermatophyte infections but have limited effectiveness against yeast

Dosage: shorter treatment period with less likelihood of relapse; applied twice daily

Adverse events: burning and irritation

Griseofulvin

Action: deposits in keratin precursor cells increasing new keratin resistance to fungal invasion.

Adverse events: nausea, vomiting, diarrhea, headache, or photosensitivity.

Interactions: increases levels of warfarin (Coumadin) and decreases levels of barbiturates and cyclosporine (Sandimmune). It may decrease the efficacy of oral contraceptives and may cause a serious and unpleasant reaction with alcohol.

Systemic Allylamine Antifungals

Action: inhibits squalene epoxidase, a key enzyme in fungal biosynthesis, causing a deficiency of ergosterol causing fungal cell death

Dosage: fingernail onychomycosis: 250 mg/d for 6 weeks; toenail onychomycosis: 250 mg/d for 12 weeks

Adverse events: diarrhea, dyspepsia, rash, increase in liver enzymes, and headache

Interactions: potentiated by cimetidine (Tagamet) and antagonized by rifampin (Rifadin)

Systemic Azole Antifungals

Action: inhibit cytochrome P-450 (CYP) enzymes and fungal 14-a-demethylase, inhibiting synthesis of ergosterol. Systemic therapy is required for tinea capitis and tinea unguium.

Dosage: dosage of itraconazole is 200 mg once daily for 12 weeks for toenail infection. For fingernail infection, the dose is 200 mg twice daily for 1 week, then 3 weeks off, and repeat dosing with 200 mg twice daily for 1 week.

Selecting the Appropriate Agent for Tinea

Tinea capitis

First line: griseofulvin (Grifulvin V) minimum 8 weeks

Second line: terbinafine (Lamisil) or itraconazole (Sporanox) 4 weeks

Tinea corporis, tinea cruris, tinea pedia

First line: topical azole antifungals for 2 to 4 weeks (1 week past clinical cure), 2 weeks even after rash is gone

Second line: systemic therapy: terbinafine (Lamisil) or fluconazole (Diflucan)

Selecting the Appropriate Agent for Tinea (cont.)

Onychomycosis

First line: itraconazole (Sporanox) or terbinafine (Lamisil) 12 weeks with food; not recommended for children

Tinea versicolor

First line: selenium sulfide solution 1% or 2.5% topical azole cream or spray for localized lesions

Second line: itraconazole (Sporanox)

Patient Education for Tinea

Teach hygiene and ways to avoid transferring fungal infection to others.

Complete the full course of treatment and do not stop treatment when symptoms subside.

Inform parents and other caregivers that children can attend school while being treated.

Dry areas susceptible to fungus with a hair dryer after bathing.

Use antifungal powder and sprays for prophylaxis.

Tinea Versicolor (Pityriasis Versicolor)

An opportunistic superficial yeast infection

Causes: overgrowth of the hyphal form of Pityrosporum ovale; occurs mostly in subtropical and tropical areas

Action: an enzyme oxidizes fatty acids in the skin surface lipids, forming dicarboxylic acids, which inhibit tyrosinase in epidermal melanocytes and cause hypomelanosis

Diagnostic criteria: well-defined skin lesions, round or oval macules with an overlay of scales forming on the trunk, upper arms, and neck with mild itching; confirmed by positive KOH test

Candidiasis

Superficial fungal infection of the skin and mucous membranes.

Causes: C. albicans occurs on moist cutaneous sites in people with infection or diabetes, or using systemic and topical corticosteroids, and with immunosuppression.

Action: C. albicans invades the epidermis when warm, moist conditions prevail.

Diagnostic criteria: red, moist papules, or pustules found in the axillae, inframammary areas, groin, and between the fingers and toes.

Order of Treatment for Candidiasis

First line: cool soaks with Burow solution, topical azole for 10 days, oral nystatin

Second line: itraconazole (Sporanox) or fluconazole (Diflucan)

Complementary and Alternative Medicine

Apple cider vinegar

Palin yogurt

Tea tree oil

Tea

Three Groups of Viruses Producing Skin Lesions

Herpes viruses: replicate their own polymerase, along with several of their own enzymes

Papilloma viruses: contribute to the initiation of DNA replication

Pox viruses: replicate entirely in the cytoplasm

Viruses

Viruses are obligate intracellular parasites consisting of a nucleic acid core surrounded by one or more proteins.

A host cell is required for viral replication.

Several mechanisms exist for viral replication, and different DNA viruses replicate by their own specific mechanism.

Seven Types of Herpes Virus Infections

Herpes simplex type 1 (HSV-1): involves the

Our website has a team of professional writers who can help you write any of your homework. They will write your papers from scratch. We also have a team of editors just to make sure all papers are of HIGH QUALITY & PLAGIARISM FREE. To make an Order you only need to click Ask A Question and we will direct you to our Order Page at WriteDemy. Then fill Our Order Form with all your assignment instructions. Select your deadline and pay for your paper. You will get it few hours before your set deadline.

Fill in all the assignment paper details that are required in the order form with the standard information being the page count, deadline, academic level and type of paper. It is advisable to have this information at hand so that you can quickly fill in the necessary information needed in the form for the essay writer to be immediately assigned to your writing project. Make payment for the custom essay order to enable us to assign a suitable writer to your order. Payments are made through Paypal on a secured billing page. Finally, sit back and relax.

Do you need an answer to this or any other questions?